1. The use of economic evidence by healthcare decision makers;Drummond;Eur J Heal Econ.,2001
2. Programme costs in the economic evaluation of health interventions;Johns;Cost Eff Resour Alloc.,2003
3. Multiple chronic conditions and healthcare costs among adults;Sambamoorthi;Expert Rev Pharmacoecon Outcomes Res.,2015
4. Banthin JS, Miller E. Persistence in medicare prescription drug expenditures by treatment class. Rockville, MD: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services; 2006. Working Paper No.: 06006. (Consultado el 5/4/2016). Disponible en: http://meps.ahrq.gov/mepsweb/data_files/publications/workingpapers/wp_06006.pdf
5. The utility of extended longitudinal profiles in predicting future health care expenditures;Cohen;Med Care.,2006